Source: Eur Respir J, 59 (1) 2101531; 10.1183/13993003.01531-2021



Rating:

Share or cite this content

Citations should be made in the following way:
Catharina C. Moor, Remy L.M. Mostard, Jan C. Grutters, Paul Bresser, Marlies S. Wijsenbeek. The use of online visual analogue scales in idiopathic pulmonary fibrosis. Eur Respir J, 59 (1) 2101531; 10.1183/13993003.01531-2021

Member's Comments

No comment yet.

Related content which might interest you: Patient-reported outcomes in idiopathic pulmonary fibrosis; validity and reliability of visual analogue scales Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Negative visual representation of chronic obstructive pulmonary disease occurs online Source: ERJ Open Res, 6 (4) 00549-2020; 10.1183/23120541.00549-2020 Year: 2020 Item generation for a patient reported outcome measure (PRoM) in idiopathic pulmonary fibrosis (IPF): Application of consensus methods Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Visual and fully-automated CT analysis in acute exacerbations of idiopathic pulmonary fibrosis (IPF) Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Cost-effectiveness of an online homemonitoring program in idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021 A comparison of published multidimensional indices to predict outcome in idiopathic pulmonary fibrosis Source: ERJ Open Res, 3 (1) 00096-2016; 10.1183/23120541.00096-2016 Year: 2017 A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis Source: Eur Respir J 2010; 36: 1067-1072 Year: 2010 Clinical burden of idiopathic pulmonary fibrosis (IPF): physician and patient perception Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 A global registry for idiopathic pulmonary fibrosis: the time is now Source: Eur Respir J 2014; 44: 273-276 Year: 2014 Does a visual analogue scale assist in the assessment of the use of nebulised bronchodilators for moderate/severe COPD patients? Source: Eur Respir J 2002; 20: Suppl. 38, 622s Year: 2002 The changing treatment landscape in idiopathic pulmonary fibrosis Source: Eur Respir Rev 2015; 24: 65-68 Year: 2015 The development of a measure to better understand patient experiences with pirfenidone and nintedanib for the treatment of idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 3 (4) 00084-2017; 10.1183/23120541.00084-2017 Year: 2017 Pirfenidone treatment in idiopathic pulmonary fibrosis: too much of a great expectation Source: Eur Respir J 2012; 40: 794-795 Year: 2012 Initial clinical experience with nintedanib for treatment of idiopathic pulmonary fibrosis (IPF): About 20 cases Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 An electronic nose can sniff out idiopathic pulmonary fibrosis. Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 The reliability and validity of the 4 metre gait speed (4MGS) in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – Best abstracts in exercise capacity and testing in chronic lung diseases Year: 2016 The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 25: 96-103 Year: 2005 Comparison of densitometric and visual scoring in the assessment of severity of idiopathic fibrotic interstitial pneumonias: Preliminary observations Source: International Congress 2015 – New insights into IIPs Year: 2015